Literature DB >> 22937696

Diagnosis and treatment of chronic viral hepatitis B and C: doctrinary approach.

Azra Husic-Selimovic1, Zora Vukobrat-Bijedic, Milenko Bevanda, Rusmir Mesihovic, Enver Zerem, Sead Ahmetagic, Stevan Trbojevic, Antonija Verhaz, Zdravka Kezic, Muharem Zildzic, Janja Bojanic, Jasminka Petrovic, Vildana Stojic, Merdina Ferhatovic, Nevzeta Ibrahimpasic, Visnja Mrdjen, Nera Zivlak, Tatjana Barac, Helien Bebek-Ivankovic, Lejla Calkic, Maja Karin, Aleksandar Dobrovoljski, Romana Rajic, Milan Skrbic, Nenad Babic, Daniela Bevanda-Glibo.   

Abstract

Association of Gastroenterologists and Hepatologists of Bosnia and Herzegovina based on the experiences of domestic and foreign centers operating in the field of hepatology and accepted guidelines of the European and the U.S. Association for Liver Diseases adopted the consensus for the diagnosis and treatment of chronic viral hepatitis B and C. The guidelines are intended for specialists in gastroenterology and hepatology, and infectious diseases physicians working in primary health care and family medicine, but also other physicians who are confronted with this disease in their practice, with the aim of facilitating and shortening the diagnostic and treatment protocols of patients with chronic viral hepatitis B and C. This ensures faster, more efficient, more rational and cost-effective care of patients with hepatitis, with an emphasis on stopping the deterioration of liver disease to liver cirrhosis and eventually hepatocellular carcinoma. Key words: Chronic hepatitis B and

Entities:  

Mesh:

Year:  2012        PMID: 22937696     DOI: 10.5455/medarh.2012.66.s56-s68

Source DB:  PubMed          Journal:  Med Arch        ISSN: 0350-199X


  3 in total

Review 1.  Economic evaluation of HBV vaccination: A systematic review of recent publications (2000-2013).

Authors:  Giuseppe La Torre; Alice Mannocci; Rosella Saulle; Vittoria Colamesta; Angela Meggiolaro; Daniele Mipatrini; Alessandra Sinopoli
Journal:  Hum Vaccin Immunother       Date:  2016-04-22       Impact factor: 3.452

2.  Are there national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs? A survey of 33 European countries.

Authors:  Mojca Maticic; Jerneja Videcnik Zorman; Sergeja Gregorcic; Eberhard Schatz; Jeffrey V Lazarus
Journal:  BMC Infect Dis       Date:  2014-09-19       Impact factor: 3.090

3.  The Effect of Combination Antiviral Therapy in the Treatment of Hepatitis C on the Occurrence of Depressive Disorder in Patients Treated for Hepatitis C in the Republic of Srpska.

Authors:  Visnja Banjac; Nera Zivlak-Radulovic; Mirjana Miskovic
Journal:  Med Arch       Date:  2016-04-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.